Has Marie Charles received payments from drug or device companies?

Yes. Drug and device makers reported $11,404 in general payments to Marie Charles across 121 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marie Charles did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marie Charles come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marie Charles

Child & Adolescent Psychiatry · Brooklyn, NYNPI 1447407507

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,923 of the $11,404 with a category attached, or 78.2%. 15 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 28.9% of the total. Among child & adolescent psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,404in general payments, 2019–2025

Across 121 payments — averaging $94.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$3K
Neurocrine Biosciences, Inc.$3K
Johnson & Johnson$1K
Teva Pharmaceuticals USA, Inc.$1K
Alkermes, Inc.$559
Otsuka America Pharmaceutical, Inc.$518
plus $1K from 9 others

What the payments were for

Consulting fees$2,23020%
Travel & lodging$2512%
Food & beverage$8,92378%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	12	$3,292
Neurocrine Biosciences, Inc.	41	$3,121
Johnson & Johnson	15	$1,379
Teva Pharmaceuticals USA, Inc.	19	$1,325
Alkermes, Inc.	7	$559
Otsuka America Pharmaceutical, Inc.	8	$518
Luye Pharma (USA) Ltd.	8	$281
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$254
AbbVie	1	$125
Phathom Pharmaceuticals, Inc.	1	$125
Takeda Pharmaceuticals U.S.A., Inc.	1	$119
Gilead	1	$119
Axsome Therapeutics, Inc.	1	$110
Lundbeck LLC	3	$61
Medline Industries LP	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,404 in reported general payments places this provider in the 95th percentile of 317 child & adolescent psychiatry providers in New York.

See all child & adolescent psychiatry providers in New York →

Other child & adolescent psychiatry in Brooklyn

Felix SterlingBrooklyn$6K
Fahim QureshiBrooklyn$6K
Faina YablochnikovaBrooklyn$3K
Zu FashanBrooklyn$3K
Mirielle DupervalBrooklyn$2K
Mastan LokireddyBrooklyn$2K
Manoj ShahBrooklyn$1K
Matthew LorberNew York$398K
Mitchell CabisudoNew Windsor$346K
Parinda ParikhWhite Plains$185K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →